A new review of research suggests that mycobacteriophages, which are viruses that infect bacteria, could become valuable tools against drug-resistant mycobacterial infections. These infections, which include diseases like tuberculosis, are becoming harder to treat as bacteria evolve to resist antibiotics.
The review looked at how these phages might be used not only for treatment but also for rapid diagnosis, environmental surveillance, and managing occupational exposure. The idea is part of a "One Health" approach, meaning it considers human, animal, and environmental health together.
It is important to note that this is a review of existing studies, not a new clinical trial. The evidence comes from laboratory and early-stage research, not from tests in human patients. No data on safety or side effects were reported in the review.
For now, mycobacteriophages remain a promising area of research, but they are not yet a proven treatment. Patients with drug-resistant infections should continue to follow their doctor's advice and standard treatment plans.
